The trademark application INFILBREY was filed by Genzyme Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on November 8, 2022, and it was registered by office on February 15, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).